Location History:
- Lawrenceville, NJ (US) (2006)
- Trenton, NJ (US) (2012)
Company Filing History:
1 out of 41 
1 out of 3,685 
Years Active: 2006-2012
Title: The Innovations of Donald R. Hawken
Introduction
Donald R. Hawken is a notable inventor based in Trenton, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the area of G-protein coupled receptors. With a total of 2 patents, his work has implications for both diagnostics and therapeutics.
Latest Patents
Hawken's latest patents include innovative polynucleotides encoding splice variants of the human G-protein coupled receptor HGPRBMY29. The first patent provides novel polynucleotides encoding HGPRBMY28 and HGPRBMY29 polypeptides, along with their fragments and homologues. It also details methods for producing these polypeptides, including vectors, host cells, and antibodies. Furthermore, the invention outlines diagnostic and therapeutic methods for utilizing these polypeptides in the treatment and prevention of various diseases. The second patent similarly focuses on the polynucleotides encoding the splice variant HGPRBMY29sv1, emphasizing the same applications and methods as the first.
Career Highlights
Throughout his career, Donald R. Hawken has worked with prominent companies, including Bristol-Myers Squibb Company. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in medical research and development.
Collaborations
Hawken has collaborated with esteemed colleagues such as John N. Feder and Chandra S. Ramanathan. These partnerships have further enriched his research and innovation efforts.
Conclusion
Donald R. Hawken's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of novel therapeutic methods and diagnostic tools.